Anteotech Ltd · ASX:ADO
Anteotech — Anteo Diagnostics — Australian Microcap Investment Conference 2013
20 slides from Anteotech's conference presentation, Oct 22, 2013
Slide 1: Mix&Go – A Universal Glue for Clinical Diagnostics, Life Sciences and Beyond
For personal use only TM Mix&Go – A Universal “Glue” For Clinical Diagnostics, Life Sciences and Beyond Australian Microcap Investment Conference Melbourne, October 23, 2013 Dr. Geoff Cumming, CEO Anteo Diagnostics Ltd (ASX:ADO)
Slide 2: Forward Looking Statement
Forward Looking Statement For personal use only The purpose of the presentation is to provide an update of the business of Anteo Diagnostics (ASX:ADO). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. Ac
Slide 3: Anteo Diagnostics Overview
Anteo Diagnostics Overview A Biotech company with highly experienced Board and Management team For personal use only D evelops, manufactures and commercialises proprietary surface coatings for healthcare industry O ur Mix&GoTM is a novel “glue” with a ubiquitous array of applications Diagnostics (IV
Slide 4: Anteo – Corporate Overview
Anteo – Corporate Overview For personal use only Revenues from product sales Business Model Royalties from license agreements Paid R&D collaborations with IVD & LS companies Proprietary technology licensed to major Proven Technology Platform international healthcare companies with additional deals a
Slide 5: Recent Highlights
Recent Highlights For personal use only Commercial agreements 02/13 Partnership agreement with U.S. based One World Lab 02/13 Commenced paid feasibility study with global leader in lateral flow POC test manufacture 05/13 Sales partnership agreement with Spanish based Gennova Scientific for Europe &
Slide 6: Company Snapshot
Company Snapshot For personal use only Corporate Snapshot Board ASX ADO Mr. Mark Bouris – Non-Executive Chairman Cash $3.10M Market Cap. $49 M Dr. Geoff Cumming – Chief Executive Officer 52 week high 7c Ms. Sandra (Sam) Andersen – Non-Executive Director 52 week low 5c Mr. Richard Martin – Executive
Slide 7: Mix&Go – A Game Changing Technology
Mix&Go – For personal use only A Game Changing Technology
Slide 8: Mix&Go - A Game Changing Technology
Mix&Go - A Game Changing Technology Surface coatings are crucial in many industries and serve many purposes, e.g.: For personal use only • Provide adhesive properties, i.e. act like a “glue” • Confer optical properties • Add magnetic or electrical properties Mix&Go is a universal “glue” that is uniq
Slide 9: Current Focus: Diagnostics and Life Sciences
Current Focus: Diagnostics and Life Sciences For personal use only • Global IVD: $44B (2011) • Immunoassays: $8.8B Laboratory Diagnostics • Drivers: aging population = more tests, higher Asian demand, technology innovations • $8 B (2011) • $38B (2017 forecast) • Drivers: price pressure, lack of Poin
Slide 10: Mix&Go – The Secret Sauce
Mix&Go – The Secret Sauce For personal use only 3D structure is Orientation is Undamaged, Proprietary solution: damaged random oriented metal polymers Without Mix&Go With Mix&Go Consequences Characteristics Benefits Vast majority of proteins are non- Undamaged, fully functional proteins on Increased
Slide 11: The Proof Is In The Data
The Proof Is In The Data Mix&Go™ Traditional Improvement For personal use only Sensitivity IL4 0.05 pg/mL 0.2 pg/mL 4x Sensitivity improvement 4 to 50-fold! Troponin I 5 pg/mL 50 pg/mL 10x TNF-α 5 pg/mL > 250 pg/mL 50x HBcAg <10 pg/mL 150 pg/mL 15x TSH <0.001 uIU/mL 0.006 uIU/mL 6x Cost Mix&Go™ Trad
Slide 12: Mix&Go – Better Tests Faster!
Mix&Go – Better Tests Faster! Mix&Go can improve all aspects of test development and manufacture so better For personal use only tests can be developed faster New Test Possible Performance Is Key, for fragile proteins e.g. sensitivity, limit of detection Fast Development Increases speed to market Ea
Slide 13: Bioseparations – A Significant Market Opportunity
Bioseparations – For personal use only A Significant Market Opportunity
Slide 14: Bioseparation or How to Get a Pure Protein
Bioseparation or How to Get a Pure Protein For personal use only Bioseparation: isolating rare proteins or cells from a complex mixture without contamination, e.g. the purification of • Therapeutic antibodies/biologic drugs • Vaccines for human and veterinary use • Rare cells, e.g. stem cells or cir
Slide 15: Bioseparation – The Opportunity
Bioseparation – The Opportunity For personal use only Current Approach Paradigm Shift Chromatography: With Mix&Go magnetic separation can • Time consuming become reality • Expensive • technically superior solution • Hard to automate • economically advantageous • Capacity constraints Alternative Larg
Slide 16: Bioseparations: Why Now?
Bioseparations: Why Now? For personal use only Internal Drivers External Drivers • Proof of concept - Mix&Go • Increased importance - approaches show better Biologics/protein drugs play an performance than conventional ever more important role:7 out of methods the top 10 drugs sold in 2012 were biol
Slide 17: Additional Opportunities
Additional Opportunities Capitalise on For personal use only Diagnostics/POC Life Science Research Expand on Capitalise on Diagnostics/POC Bioseparations Life Science Research Expand on Cleantech,Resources Develop Bioseparations Drug screening Capitalise on Diagnostics/POC Life Science Research Init
Slide 18: Targets and Timeline
Targets and Timeline • Agreement w/ top tier IVD For personal use only • Agreement with top-tier • Agreement(s) w/ mid-tier IVD POC company • Agreement(s) w/ POC company • 2-3 agreements with LS companies • Deal(s) w/ LS companies • Agreement with top-tier POC company • Agreement with mid-size IVD •
Slide 19: Keypoints
Keypoints For personal use only • Mix&Go is a proprietary platform technology with broad applicability in diagnostics, life sciences, bioseparations and beyond • Mix&Go is proven licensed and gaining significant traction in commercial markets • Mix&Go success means Anteo is becoming cash flow positi
Slide 20: Contact Information
Contact Information Thank you very much for your interest in Anteo Diagnostics For personal use only For more information please contact:
Anteo Diagnostics — Australian Microcap Investment Conference 2013 on 6ix